SREBF1 and fatty liver disease: In mice, PXR activation results in hepatic steatosis due to enhanced sterol regulatory element-binding protein-1c (SREBP-1c)-independent lipogenesis, decreased β-oxidation, and increased uptake of fatty acids via fatty acid translocase (FAT/CD36) activation (Zhou et al., 2006b).